Cystatin C‐based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia

BACKGROUND: Although many clinical parameters have been identified as predictors for cardiovascular disease (CVD) development in the general population, the accurate predictor for CVD in patients with obesity is still unknown. OBJECTIVE: The study aimed to explore an additional risk factor and predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Keita, Tsujiguchi, Hiromasa, Hara, Akinori, Nakamura, Hiroyuki, Kotani, Kazuhiko, Noda, Mitsuhiko, Yamakage, Hajime, Satoh‐Asahara, Noriko, Takamura, Toshinari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
SPECIAL SECTION: OBESITY IN ASIA
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913198/
https://www.ncbi.nlm.nih.gov/pubmed/36789028
http://dx.doi.org/10.1002/osp4.630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913198/
https://www.ncbi.nlm.nih.gov/pubmed/36789028
http://dx.doi.org/10.1002/osp4.630

Ejemplares similares